-Mid Day   A visit to the APMC in Vashi revealed that calcium carbide - referred to as ‘carpet' by traders - which is known to cause cancer, food poisoning, nausea etc - is being used indiscriminately to ripen the fruit faster, so as to increase sales Think before you sink your teeth into those juicy, delicious mangoes. For, they could have been ripened artificially using calcium carbide, a deadly chemical that is...

-The Times of India   NEW DELHI: The World Health Organisation's (WHO) work of setting up norms and standards for production of medicines seems to be flawed by a fundamental conflict of interest. At the heart of its standard setting work is an entity the International Conference on Harmonization (ICH) in which majority of the WHO member countries have no voting rights and which is dominated by pharmaceutical industry groups. This glaring...

-The Hindu A strong whistle-blower protection law in India would expose financial corruption in a way that reinforces ethical business practices In 2013, generic pharmaceutical company Ranbaxy pleaded guilty to seven criminal felonies for drug manufacturing fraud and agreed to cough up an unprecedented $500 million in fines. The case against Ranbaxy was significant not only for being a successful prosecution of a powerful India corporation. It also marked the triumph of Dinesh...

-The Hindu In the case of technologies with benefits and risks, it is important to have regulatory mechanisms which can help analyse them in an impartial manner It is 61 years since the beginning of new genetics based on the discovery of the double helix structure of the DNA molecule. It is also 31 years since the production of transgenic plants. The first patent for a living organism went to Dr. Anand...

-The Hindu Unless a deeper, institutional change is ushered in to break the nexus between drug companies and the regulatory regime, Indians consuming drugs may be exposing themselves to serious risks Even before I walked into the Mayflower Hotel in the heart of Washington on a crisp autumn afternoon to meet Dinesh Thakur, whistle-blower and former director of India-based pharmaceutical giant Ranbaxy, I had a hunch that this conversation would spark some...